Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9)

IMPORTANCE: Sensitive outcome measures for disease progression are needed for treatment trials of Stargardt disease. OBJECTIVE: To describe the yearly progression rate of atrophic lesions in the retrospective Progression of Stargardt Disease study. DESIGN, SETTING, AND PARTICIPANTS: A multicenter re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA Ophthalmol
Hauptverfasser: Strauss, Rupert W., Muñoz, Beatriz, Ho, Alexander, Jha, Anamika, Michaelides, Michel, Cideciyan, Artur V., Audo, Isabelle, Birch, David G., Hariri, Amir H., Nittala, Muneeswar G., Sadda, SriniVas, West, Sheila, Scholl, Hendrik P. N.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Medical Association 2017
Schlagworte:
Original Investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710470/
https://ncbi.nlm.nih.gov/pubmed/29049437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2017.4152
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge